PRDX4 and idiopathic pulmonary fibrosis: Similarly, studies analyzing human serum samples obtained from IPF patients have shown that PRDX4 (peroxiredoxin-4) is associated with the aggravation of inflammatory changes and fibrotic effects in the pathogenesis of IPF [27].